Fox Foundation Grant to Help Advance CNM-Au8 to Planned Phase 2 Trial

Fox Foundation Grant to Help Advance CNM-Au8 to Planned Phase 2 Trial

288644

Fox Foundation Grant to Help Advance CNM-Au8 to Planned Phase 2 Trial

A grant from the Michael J. Fox Foundation (MJFF) will help Clene Nanomedicine to advance in development CNM-Au8, its cellular energy-promoting, investigational Parkinson’s treatment. The grant will help to support preclinical studies in patients’ nerve cells and mouse models of the disease, as well as facilitate the launch of a Phase 2 safety and effectiveness study of CNM-Au8 in Parkinson’s patients. Clene plans to initiate this clinical trial before the year’s close. “It is an honor to have the support of MJFF as we…

You must be logged in to read/download the full post.